82 related articles for article (PubMed ID: 16189274)
1. Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.
Tjin EP; Groen RW; Vogelzang I; Derksen PW; Klok MD; Meijer HP; van Eeden S; Pals ST; Spaargaren M
Blood; 2006 Jan; 107(2):760-8. PubMed ID: 16189274
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
Matteucci E; Ridolfi E; Desiderio MA
Cell Mol Life Sci; 2006 Sep; 63(17):2016-26. PubMed ID: 16909210
[TBL] [Abstract][Full Text] [Related]
3. Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines.
Phillip CJ; Zaman S; Shentu S; Balakrishnan K; Zhang J; Baladandayuthapani V; Taverna P; Redkar S; Wang M; Stellrecht CM; Gandhi V
J Hematol Oncol; 2013 Dec; 6():92. PubMed ID: 24326130
[TBL] [Abstract][Full Text] [Related]
4. Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development.
Ieraci A; Forni PE; Ponzetto C
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15200-5. PubMed ID: 12397180
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.
Watson GA; Zhang X; Stang MT; Levy RM; Queiroz de Oliveira PE; Gooding WE; Christensen JG; Hughes SJ
Neoplasia; 2006 Nov; 8(11):949-55. PubMed ID: 17132227
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of the HGF/Met pathway leads to thyroid dysgenesis by impeding late thyroid expansion.
Fang Y; Wan JP; Wang Z; Song SY; Zhang CX; Yang L; Zhang QY; Yan CY; Wu FY; Lu SY; Sun F; Han B; Zhao SX; Dong M; Song HD
Nat Commun; 2024 Apr; 15(1):3165. PubMed ID: 38605010
[TBL] [Abstract][Full Text] [Related]
7. c-Met as a Target for Personalized Therapy.
Garajová I; Giovannetti E; Biasco G; Peters GJ
Transl Oncogenomics; 2015; 7(Suppl 1):13-31. PubMed ID: 26628860
[TBL] [Abstract][Full Text] [Related]
8. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.
Loh ML; Sakai DS; Flotho C; Kang M; Fliegauf M; Archambeault S; Mullighan CG; Chen L; Bergstraesser E; Bueso-Ramos CE; Emanuel PD; Hasle H; Issa JP; van den Heuvel-Eibrink MM; Locatelli F; Stary J; Trebo M; Wlodarski M; Zecca M; Shannon KM; Niemeyer CM
Blood; 2009 Aug; 114(9):1859-63. PubMed ID: 19571318
[TBL] [Abstract][Full Text] [Related]
9. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive molecular characterization of human colon and rectal cancer.
Cancer Genome Atlas Network
Nature; 2012 Jul; 487(7407):330-7. PubMed ID: 22810696
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.
Arcila ME; Chaft JE; Nafa K; Roy-Chowdhuri S; Lau C; Zaidinski M; Paik PK; Zakowski MF; Kris MG; Ladanyi M
Clin Cancer Res; 2012 Sep; 18(18):4910-8. PubMed ID: 22761469
[TBL] [Abstract][Full Text] [Related]
12. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.
Wang LE; Ma H; Hale KS; Yin M; Meyer LA; Liu H; Li J; Lu KH; Hennessy BT; Li X; Spitz MR; Wei Q; Mills GB
J Cancer Res Clin Oncol; 2012 Mar; 138(3):377-85. PubMed ID: 22146979
[TBL] [Abstract][Full Text] [Related]
13. The mutational landscape of head and neck squamous cell carcinoma.
Stransky N; Egloff AM; Tward AD; Kostic AD; Cibulskis K; Sivachenko A; Kryukov GV; Lawrence MS; Sougnez C; McKenna A; Shefler E; Ramos AH; Stojanov P; Carter SL; Voet D; Cortés ML; Auclair D; Berger MF; Saksena G; Guiducci C; Onofrio RC; Parkin M; Romkes M; Weissfeld JL; Seethala RR; Wang L; Rangel-Escareño C; Fernandez-Lopez JC; Hidalgo-Miranda A; Melendez-Zajgla J; Winckler W; Ardlie K; Gabriel SB; Meyerson M; Lander ES; Getz G; Golub TR; Garraway LA; Grandis JR
Science; 2011 Aug; 333(6046):1157-60. PubMed ID: 21798893
[TBL] [Abstract][Full Text] [Related]
14. S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.
Lin Q; Su J; Fang Y; Zhong Z; Chen J; Zhang C
Front Oncol; 2024; 14():1344669. PubMed ID: 38361783
[TBL] [Abstract][Full Text] [Related]
15. Follicular lymphoma microenvironment: insights provided by single-cell analysis.
Abe Y
J Clin Exp Hematop; 2023 Sep; 63(3):143-151. PubMed ID: 37635086
[TBL] [Abstract][Full Text] [Related]
16. B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer.
Pathmanathan S; Yao Z; Coelho P; Valla R; Drecun L; Benz C; Snider J; Saraon P; Grozavu I; Kotlyar M; Jurisica I; Park M; Stagljar I
iScience; 2022 Nov; 25(11):105419. PubMed ID: 36388990
[TBL] [Abstract][Full Text] [Related]
17. c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance.
Stanislovas J; Kermorgant S
Front Cell Dev Biol; 2022; 10():994528. PubMed ID: 36330337
[TBL] [Abstract][Full Text] [Related]
18. IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis.
Chu PY; Huang WC; Tung SL; Tsai CY; Chen CJ; Liu YC; Lee CW; Lin YH; Lin HY; Chen CY; Yeh CT; Lin KH; Chi HC
Cell Biosci; 2022 Aug; 12(1):124. PubMed ID: 35941699
[TBL] [Abstract][Full Text] [Related]
19. Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method.
Yeh SJ; Yeh TY; Chen BS
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743172
[TBL] [Abstract][Full Text] [Related]
20. A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling.
Abe Y; Sakata-Yanagimoto M; Fujisawa M; Miyoshi H; Suehara Y; Hattori K; Kusakabe M; Sakamoto T; Nishikii H; Nguyen TB; Owada Y; Enomoto T; Sawa A; Bando H; Yoshida C; Tabata R; Terao T; Nakayama M; Ohshima K; Usuki K; Oda T; Matsue K; Chiba S
Nat Cell Biol; 2022 Apr; 24(4):565-578. PubMed ID: 35332263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
